Theme: Innovation and future trends of Cytopathology & Histopathology

Cytopathology 2016

Renowned Speakers

Cytopathology 2016

Keynote Speakers Cytopathology-2016, USA

Shahla Masood is a Persian-born physician, who currently holds the positions of Professor and Chair of the Department of Pathology at University of Florida College of Medicine – Jacksonville and Chief of Pathology and Laboratory Medicine at Shands Jacksonville. She is also the Director of the Pathology Residency Training Program, as well as Cytopathology and Breast Pathology Fellowship Training Program. In addition, Dr. Masood is the Medical Director of Shands Jacksonville Breast Health Center. An internationally recognized expert in breast cancer diagnosis and prognosis, Dr. Masood has fostered the concept of an integrated multidisciplinary approach in breast cancer care, research, and education. Dr. Masood has recently been appointed to chair a committee of the National Accreditation Program for Breast Centers (NAPBC) with a new initiative to explore the possibility of expansion of this program to an international level.
Shahla Masood
Professor and Chair
University of Florida College of Medicine – Jacksonville, USA
Hameed Benghuzzi received his Master in Chemistry and Ph.D. in biological Sciences with a concentration in physiology from the University of Dayton in Ohio. In 1993, he completed postdoctoral training in the pathology department at the University of Michigan Medical center. Thereafter, he joined the university of Mississippi Medical Center and currently he is the professor in the department of diagnostic and clinical health sciences. He is a fellow of the American Institute of Medical and Biological Engineering, as well as, International Fellow of the World Congress of Biomaterials Societies (Japanese, American, Asian, and European). He is a pioneer scientist in ceramic drug delivery systems. His area of research is the development and applications of novel ceramic drug delivery systems (over 26 years/over 300 publications and 600 abstracts at various meetings). He served and serving as a major advisor for over 35 Ph.D. students as well as a mentor for students at various levels (High school, undergraduate, MS, residents and postdoctoral). He received Nemours awards and honors from very prestigious societies and organizations. He was invited as a keynote speaker at state, national and international levels. His recent research was the first, worldwide, to histopathological identify the role of sustained delivery of reproductive hormones in the induction of azoospermia.
Hamed A. Benghuzzi
Professor and Chair of Diagnostic and Clinical Health Sciences
University of Mississippi Medical Center, USA
Li is an internationally recognized expert in the field of cytopathology and co-PI in Johns Hopkins Biomarker Discovery Center. She provides diagnostic service at Johns Hopkins and conducts research in the field of novel biomarkers in lung and prostate cancers. Her research has been presented at many national/international meetings. Dr. Li also serves as editorial board members for several journals, committee member of the American Society of Cytopathology, and study sections of government agents and private organizations. She has more than 70 publications and book chapters. Dr. Li is also the editor of “Diagnostic Cytopathology Board Review and Self-Assessment”.
Qing Kay Li
Committee Member of American Society of Cytopathology
The Johns Hopkins University School of Medicine, USA
Sin Hang Lee, M.D. graduated from Wuhan Medical College in China. After a residency fellowship at Cornell-New York Hospital and Memorial Hospital for Cancer, Dr. Lee was certified by the American Board of Pathology and obtained the F.R.C.P. (C) degree by examination in 1966. He was on the faculty of McGill University and Yale University from 1968-2004 while practicing hospital-based pathology. Dr. Lee is currently the director of Milford Molecular Diagnostics, Milford, Connecticut. In the past 10 years, Dr. Lee has developed Sanger sequencing-based testing methods for HPV, Neisseria gonorrhoeae, Chlamydia trachomatis, Lyme disease borreliae and Ebolavirus implementable in community hospitals.
Sin Hang Lee
Director, Milford Molecular Diagnostics, USA
Taniyama completed his Ph.D. in Pathology at the Hiroshima University School of Medicine in Japan in 1985, and he learned molecular techniques and laser capture microdissection at the University of California, San Diego Cancer Center in 1998-99. He joined the National Hospital Organization (NHO), Kure Medical Center and Chugoku Cancer Center in 2002, and he became the president of this center in July 2014.
Kiyomi TANIYAMA
President, National Hospital Organization (NHO)
Japan
Guo-Min Deng has obtained MD in China and Ph.D. in Gothenburg University, Sweden in 2001. He worked as research fellow in NIH, USA during 2002-2006 and worked as instructor and assistant professor at Harvard University during 2006-2014. He is a distinguished professor and the director of key Lab of antibody techniques of the ministry of health in Nanjing Medical University. He has published more than 25 papers in reputed journals including Nature Medicine, Nature reviews Rheumatology and has been serving as an editorial board member of repute.
Guo-min Deng
Director
Key Laboratory of Antibody Technique of Ministry of Health,
Nanjing Medical University
China

Speaker slot available..!!!

Cytopathology-2016 is a global event that brings together a unique and International mix of experts, researchers and decision makers both from academia and industry across the globe to exchange their knowledge, experience and research innovations to build a world Cytopathologists meet. OMICS International Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members and Organizes 300+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies.

This meet enables a common platform for the participants to discuss their research in order to establish a scientific network between the academia and industry leading to Cytopathological technologies and innovations leads to explore new possibilities and improving the existed opportunities.

For more details please visit- http://cytopathology.conferenceseries.com/   

1. Key Competitive Conferences and their no. of attendees

There are huge number of Conferences are going on Cytopathology as is an emerging field towards the diagnostic path.

2. Market research

Cytopathology therapies and Diagnostics for Cervical Cancer the global cervical cancer market for drugs and diagnostics was $11.3 billion in 2012 and is expected to grow from $11.6 billion in 2013 to $15.6 billion by 2018, a compound annual growth rate (CAGR) of 6.1%.  Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.

 

Cancer Cytopathology

Pap Smear

Veterinary Cytopathology

Gynecology Cytopathology

2013

20.3

17.8

795.4 

5

2019

31.8

21.6

1.2

8.2

 

 

 

 

 

 

3. Societies and Associations on the topic

·         American Society of Cytopathology

·         Australian Society of Cytology

·         Papanicolaou Society of Cytopathology

·         The European Federation of Cytology Societies

 

 

Las Vegas

USA

World

Association

1

2

12

Society

1

1

32

 

4. Universities Located

University of Nevada School of Medicine , USA

Henderson State University , USA

Roseman University of Health Sciences, USA

College of Southern Nevada, USA

Touro University Nevada, USA

 

Las Vega

USA

World

4

15

43

 

Target Audience:

 

 

Las Vegas

USA

World

Researcher

38

468

2488

Academia

72

206

1608

Students

144

1502

7320

 

References:

https://en.wikipedia.org/wiki/Cytopathology

:  http://www.bccresearch.com/market-research/healthcare/cervical-cancer-therapies-diagnostics-hlc141a.html

http://www.bccresearch.com/pressroom/hlc/global-market-for-surgical-equipment-expected-to-increase-$8.2-billion-2018

http://www.bccresearch.com/market-research/healthcare/optical-coherence-tomography-global-markets-technologies-oct-report-hlc097b.html          

http://www.bccresearch.com/market-research/pharmaceuticals/diagnostics-therapeutics-lung-cancer-markets-report-phm174a.html            

 

Cytopathology 2016 invites scholars, researchers, academicians, students and corporate entities across the globe to join at the 2nd International Conference on Cytopathology & Histopathology (Cytopathology-2016) to have a meaningful discussion with scholars during August 10-12, 2016 in Las Vegas, USA. The conference focuses on “Innovation and future trends of Cytopathology & Histopathology”.

Cytopathology 2016 anticipates more than 300 participants around the globe with thought provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. The attending delegates include Editorial Board Members of related Journals.

After Successful completion of Cytopathology 2015, Conference Series LLC welcomes all to join the exclusive event 2nd International Conference on Cytopathology & Histopathology, Las Vegas, Nevada, USA and showcase the recent research in the tremendous field of Cytopathology-Histopathology among the experts.

Students are warmly welcome to attend or to present their research work as Poster presenter and Young Researcher forum in this prestigious profile Cytopathologists & Histopathologists.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Who is Attending?

  • Deans/Chairs, Vice Deans & Vice Presidents of Medical Institutions and Hospitals
  • Professors and students from academia who are in the field of research, Medical and clinical research.
  • Physicians, Business delegates, Directors / Managers & Business Intelligence Experts, Departmental Managers.

Benefits of Attending the Conference

  • The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows, Certificate Accreditation from the Organizing Committee of presentation/ participation.
  • Accepted Abstracts will be published in the respective journals and will be labeled with a Digital Object Identification Number (DOI) provided by Cross Ref (Free abstract publishing).
  • Speaker and Abstract pages created in Google on your name would get worldwide acknowledgment to your profile and Research.
  • Best Poster and Young Researcher Award.

Supporting Journals:

 

Contact Person:

Robert Johnson

Program Manager | Cytopathology 2016

Phone:1-888-843-8169

Email: cytopathology@conferenceseries.net

Cytopathology Congress one of the World's best platform on Pathology events will enable to put forth the holistic scientific approach to validating existing and development of Cytopathologic and Histopathologic techniques as to better understanding of diseases and diagnosis. Cytopathology conference is set to witness an exhilarating sessions in scientific program which will focus on latest innovations in Cancer Cytopathology, Clinical & Molecular Cytopathology, Stem Cell Therapy & Anatomical Pathology, Diagnostic & Comprehensive Cytopathology, General Cytopathology & Immunocytochemistry, Cytopathology & Disease diagnosis, Forensic Cytopathology, Genome Expression Profiling, Gene therapy, Bacterial & Microbial pathology Infection control, Veterinary Cytopathology.

Cytopathology Meeting will be the platform for business delegates, B2B meetings, poster presentations, Cytopathology workshops, Cytopathology symposia and much more. Past conference of Cytopathology meeting in 2015 has grounded the best possible researchers in the field of Cytopathology & Histopathology from diverse scientific disciplines and opened the channels for research funding opportunities and collaborations, and so will be upcoming.

Track 1Cancer Cytopathology

Cytopathology usually used to aid in the diagnosis of cancer, but also helps in the diagnosis of certain infectious diseases and other inflammatory conditions. Cancer Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues. Cytopathologic tests are sometimes called smear tests because the samples may be smeared across a glass microscope slide for subsequent staining and microscopic examination. Gallbladder cancer is a relatively uncommon cancer and can be cure by fine needle aspiration material. However, cytology samples may be prepared in other ways, including cytocentrifugation. Different types of smear tests may also be used for cancer diagnosis. In this sense, it is termed a cytological smear. Epidemiology of Breast Cancer is the most commonly diagnosed cancer among women, with approximately 182,000 women diagnosed with breast cancer annually in the United States, accounting for approximately 26% of all incident cancers among women. Each year, 40,000 women die of breast cancer, making it the second-leading cause of cancer deaths among American women after lung cancer. The lifetime risk of dying of breast cancer is approximately 3.4%.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference, May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 2Histopathology

Histopathology is the science or study dealing with the cytological and histologic structure of the abnormal or diseased tissue. Although it refers to the microscopic examination of tissue in order to study the manifestations of the disease. The study of tissues is called Tissue histology and is important to the understanding of how the human body is able to function as a unit. in clinical medicine, histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, after the specimen has been processed and histological sections have been placed onto glass slides. In contrast, cytopathology examines free cells or tissue fragments. Immunohistochemistry (IHC) refers to the process of detecting antigens (e.g. proteins) in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues.

Histology, There are four basic types of tissues: muscle tissue, nervous tissue, connective tissue, and epithelial tissue. All tissue types are subtypes of these four basic tissue types (for example, blood cells are classified as connective tissue, since they generally originate inside bone marrow).

Histopathology, the microscopic study of diseased tissue, is an important tool in anatomical pathology since accurate diagnosis of cancer and other diseases usually requires histopathological samples.

Relevant Conferences:

Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 3Diagnostic Cytopathology

Diagnostic Cytopathology Essentials is a succinct yet comprehensive guide to diagnosis in both non-gynecological and gynecological cytology. It provides quick answers to diagnostic problems in the cytological interpretation and recognition of a wide range of disease entities. Diagnosis of Cancer is nearly always diagnosed by an expert who has looked at cell or tissue samples under a microscope. In some cases, tests done on the cells’ proteins, DNA, and RNA can help tell doctors if there’s cancer. These test results are very important when choosing the best treatment options. Fine needle aspiration cytology is an inexpensive, a traumatic technique for the diagnosis of disease sites. It illustrates how it may be applied to the management of tumors throughout the body. The limitations of the method, the dangers of false positive reports, and the inevitability of false negative diagnoses are emphasized. In a clinical context the method has much to offer by saving patients from inappropriate operations and investigations and allowing surgeons to plan quickly and more rationally. It is an economically valuable technique and deserves greater recognition. Esophagus cancers are usually found because of signs or symptoms a person is having. If esophagus cancer is suspected, exams and tests will be needed to confirm the diagnosis. If cancer is found, further tests will be done to help determine the extent (stage) of the cancer.

Relevant Conferences:

Clinical Pathology Conference, Sept 26-28, 2016 Toronto, Canada; Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Conference, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA;; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 5Clinical & Molecular Cytopathology

Molecular Cytopathology is an emerging discipline within Cytopathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of chemistry, microbiology, hematology and molecular pathology. Cervical cancer is the third most common type of cancer among women worldwide. The infection and persistence of human papillomavirus (HPV) are the essential conditions for this type of disease. However, only HPV infection is not enough for cervical pathogenesis are necessary cofactors and activation of intracellular and extracellular mechanisms to start.

In the conventional Pap smear, the physician collecting the cells smears them on a microscope slide and applies a fixative. In general, the slide is sent to a laboratory for evaluation. The studies include Liquid-based monolayer cytology and Human papillomavirus testing. Diagnostic molecular pathology: Recent revolutionary progress in human genomics is reshaping our approach to therapy and diagnosis

 

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Histology Conference, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 6Exfoliative Cytopathology

Exfoliative Cytopathology is the most significant and time-consuming area of practice for most anatomical pathologists. Surgical pathology involves gross and microscopic examination of surgical specimens, as well as biopsies submitted by surgeons and non-surgeons such as general internists, medical subspecialists, dermatologists, and interventional radiologists.

Relevant Conferences

Euro Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 7General Cytopathology & Immunocytochemistry

Cytology, also known as cytotechnology or cytopathology, is a specialized field in medical lab technology in which technicians examine cells for signs of cancer. Fine Needle Aspiration (FNA) is a technique used to improve the clinical management of thyroid lesions, Thyroid Cytopathology. The introduction of a standardized and reproducible terminology system for diagnosis of a particular condition should reduce the need for unnecessary investigations and operations. Standardization of terminology is expected to improve patient safety and reduce risk to patients as any positive result will be identified and acted upon quickly. Immunocytochemistry (ICC) is a common laboratory technique that is used to anatomically visualize the localization of a specific protein or antigen in cells by use of a specific primary antibody that binds to it. The primary antibody allows visualization of the protein under a fluorescence microscope when it is bound by a secondary antibody that has a conjugated fluorophore.

The American Thyroid Association (ATA) is an international membership medical society with over 1,700 members from 43 countries around the world.  The ATA delivers its mission -of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health. Likewise, Akrimax Pharmaceuticals, LLC, Bayer Healthcare/Onyx Pharmaceuticals, CBLPath, Endocrine Education, Inc. and much more are there in the tip of the growth of Cytopathology era.

Relevant Conferences:

Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK;; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 8Cervical Cytopathology

Cervical cytology became the standard screening test for cervical cancer and premalignant cervical lesions. Cytologic examinations may be performed on body fluids (examples are blood, urine, and cerebrospinal fluid) or on material that is aspirated (drawn out via suction into a syringe) of the body. Cytology also can involve examinations of preparations that are scraped or washed (irrigated with a sterile solution) from specific areas of the body. For example, a common example of diagnostic cytology is the evaluation of cervical smears (referred to as the Papanicolaou test or Pap smear).

There are several methods to screen for cervical cancer. The Pap test (also known as Pap smear or conventional cytology) and liquid-based cytology are widely used throughout the world and have been credited with greatly reducing the number of cases and mortality from cervical cancer in the developed world. Cytology-based tests have not been as effective in developing countries, leading to an investigation of cervical screening approaches more suited to low-resource settings such as visual inspection with acetic acid or HPV DNA testing.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 9Cytopathology & Disease diagnosis

 Cytology is a key component in diagnosis and screening of diseases such as cancer. Cytology disease diagnosis assesses single cells and clusters of cells from sources such as malignant effusions and peripheral blood. Effusions are fluids that leak from blood and lymph vessels and aggregate in tissues and cavities within the body. This is a common problem in cancer patients and can be a reservoir of malignant cells. However, the total number of cells in effusions is small in comparison to the volumes of fluids that are produced. Therefore, in order to collect these cells for evaluation, they must be concentrated. Liver disease diagnosis can often be difficult to diagnose because its symptoms can be vague and easily confused with other health problems. In some cases, a person may have no symptoms at all but the liver may already have suffered significant damage.

Gynecologic cytology, also gynecologic cytopathology, is a field of pathology concerned with the investigation of disorders of the female genital tract. The most common investigation in this field is the Pap test, which is used to screen for potentially precancerous lesions of the cervix. Cytology can also be used to investigate disorders of the ovaries, uterus, vagina and vulva.

A survey was conducted among 130 New York State (NYS) registered cytology laboratories to better understand current and future changes in the practice of cytology, changes in the cytotechnologist (CT) scope of practice, and the future need for CTs. A 51.5% (67/130) response rate was obtained. Trends for gynecologic case volume varied across facility types.  Non-gynecologic volume is growing primarily in hospitals and large medical center laboratories and private laboratories; the fine-needle aspiration volume is growing in hospital and large medical center laboratories. One-third of responding laboratories anticipates a continued demand for CTs within the next 3 years owing to impending retirements. Few laboratories also report the gradual adoption of molecular testing with CTs directly involved. Because 60% (3/5) of NYS CT training programs have closed since 2008, the 2 remaining programs are a valuable key staffing resource for CTs. Continued viability of these programs is essential to provide the necessary training and staffing of NYS laboratories for cytopathology practice.

Relevant Conferences:

Histology Meeting, August 11-12, 2016 New Orleans, USA; Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Molecular Pathology Conferences, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 10Veterinary Cytopathology

Veterinary Cytopathology is concerned with the diagnosis of disease based on the gross examination, microscopic, and molecular examination of organs, tissues, and whole bodies (necropsy). Veterinary pathologists are doctors of veterinary medicine who specialize in the diagnosis of diseases through the examination of animal tissue and body fluids. Other than the diagnosis of disease in food-producing animals, companion animals, zoo animals and wildlife, veterinary pathologists also have an important role in drug discovery and safety as well as scientific research. Veterinary Clinical Sciences is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids such as blood, urine or cavitary effusions, or tissue aspirates using the tools of chemistry, microbiology, hematology and molecular pathology.

The Treatment of Veterinary Diseases of veterinary diseases is possible with the Veterinary clinical science with the help of the diagnosis pattern. Among the four major geographies namely North America, Europe, Asia-Pacific and Rest of the world, European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. These two regions collectively account for more than 70% of the global veterinary vaccine market revenue.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 11Fine-needle aspiration Cytology

Fine-needle aspiration biopsy (FNAB, FNA or NAB), or fine-needle aspiration cytology (FNAC), is a diagnostic procedure used to investigate superficial (just under the skin) lumps or masses. In this technique, a thin, hollow needle is inserted into the mass for sampling of cells that, after being stained, will be examined under a microscope. There could be cytology exam of aspirate (cell specimen evaluation, FNAC) or histological (biopsy - tissue specimen evaluation, FNAB). Gene expression profiling is the measurement of the activity (the expression) of thousands of genes at once, to create a global picture of cellular function. These profiles can, for example, distinguish between cells that are actively dividing, or show how the cells react to a particular treatment. Many experiments of this sort measure an entire genome simultaneously, that is, every gene present in a particular cell. Fine-needle aspiration biopsies are very safe, minor surgical procedures. Often, a major surgical (excisional or open) biopsy can be avoided by performing a needle aspiration biopsy instead. In 1981, the first fine-needle aspiration biopsy in the United States was done at Maimonides Medical Center, eliminating the need for surgery and hospitalization. Today, this procedure is widely used in the diagnosis of cancer and inflammatory conditions. Gene expression the appearance in a phenotype of a characteristic or effect attributed to a particular gene. The process by which possession of a gene leads to the appearance of the phenotype of the corresponding character.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Conference, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 12Cytopathology Case Reports

Cytopathology is the examination of cells from the body under the microscope to identify the signs and characteristics of the disease. Cytopathology is often loosely called "cytology," a word that simply means the study of cells.

A cytopathology report tells us whether the cells studied contain signs of disease. Cells examined for cytopathology can come from fluids extracted from body cavities - e.g. urine, sputum (spit), or fluids accumulating inside the chest or abdomen. Cells can also be extracted by inserting needles into lumps or diseased areas or tissues - called fine needle aspiration cytology (FNAC).

Laboratories may include recommendations as part of the Gynaecology Case reports.  These may include a suggestion to the clinician for repeat cytology after a certain time interval or after treatment, or for tissue studies to further evaluate epithelial cell abnormalities.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 13Urine Cytology

Cytology is the examination of cells from the body under a microscope. In a urine cytology exam, a doctor looks at cells collected from a urine specimen, to see how they look and function. The test commonly checks for infection, inflammatory disease of the urinary tract, cancer, or precancerous conditions. Urine cytology is better at finding larger and more aggressive cancers than small, slow growing cancers.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 14Stem Cell Therapy & Anatomical Pathology

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Cytopathology surgical autopsy service serves multiple important functions. In addition to routine autopsy reports, this section provides sources of material for many research activities, including retrospective studies of various diseases, case reports, comparative tissue studies and studies of various physiologic functions related to a malignant disease. The service provides tissue for virologic, biochemical, molecular and electron microscopic studies.

Anatomic pathology (U.S.) is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.

The acute ischemic stroke diagnosis and treatment market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America represented the largest regional market for acute ischemic stroke primarily due to the increase in ischemic stroke surgeries and introduction of technologically advanced medical devices and products. For instance, American Heart Association stated that stroke is considered as the third leading cause of death in developed nations of the world such as the U.S., Canada. Moreover, it has also stated that there are around 795,000 patient diagnosed with stroke in the U.S. every year where 85% of the total cases were identified as acute ischemic stroke. The National Institute of Health (NIH) stated that healthcare cost for the treatment of stroke exceeds USD 73 billion in the U.S. every year. However, stringent regulatory compliance imposed by the U.S. FDA pertaining to medical device treatment utilized for the human purpose (stroke) is considered as a hurdle for the growth of this market in North America. Europe accounted for the second largest share in the global acute ischemic stroke diagnosis and treatment market in 2013.

Relevant Conferences:

Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 15: Gynecological and Breast Cytopathology

The role of the Cytopathology laboratory in the detection and presumptive identification of microorganisms. Sample procurement by exfoliation, abrasion, and aspiration techniques, as well as a variety of cytopreparatory and staining method. Gynecologic cancers are the uncontrolled growth and spread of abnormal cells originating in the female reproductive organs, including the cervix, ovaries, uterus, fallopian tubes, vagina, and vulva.

Making Strides In Breast Cancer: The most common type of breast cancer is a ductal carcinoma, which begins in the cells of the ducts. Breast cancer can also begin in the cells of the lobules and in other tissues in the breast. Invasive breast cancer is breast cancer that has spread from where it began in the ducts or lobules to surrounding tissue.

Relevant Conferences:

Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 16: Forensic Pathology

All of the disciplines of anatomic and clinical pathology, as well as other forensic sciences, are employed for the solution of medico-legal questions and cases. In the United States, a coroner is typically an elected public official in a particular geographic jurisdiction that investigates and certifies deaths. The vast majority of coroners lack a Doctor of Medicine degree and the amount of medical training that they have received is highly variable, depending on their profession (e.g. law enforcement, judges, funeral directors, emergency medical technicians, nurses).

Forensic statistics is the application of probability models and statistical techniques to scientific evidence, such as DNA evidence, and the law. In contrast to "every day" statistics, to not engender bias or unduly draw conclusions, forensic statisticians report likelihoods as likelihood ratios (LR).

In contrast, a medical examiner is typically a physician who holds the degree of Doctor of Medicine or Doctor of Osteopathic Medicine. Ideally, a medical examiner has completed both a pathology residency and a fellowship in forensic pathology. In some jurisdictions, a medical examiner must be both a doctor and a lawyer, with additional training in forensic pathology.

Relevant Conferences:

Euro Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Cytopathology-2015

International Conference on Cytopathology (Cytopathology-2015) was held during August 31-September 02, 2015 at Toronto Airport Marriott Hotel, Canada. The conference was marked with the attendance of Editorial Board Members of supported Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 30 countries, who made this conference fruitful and productive.

This conference was based on the theme “Transforming the Future of Cytopathology” which included the following scientific tracks: 

·         Cancer Cytopathology

·         General Cytopathology

·         Molecular Cytopathology

·         Veterinary Cytopathology

·         Cytopathology In Laboratory Medicine Technology

·         Infection Control Cytopathology

·         Advanced Cytopathology

·         Drug discovery in Cytopathology

·         Plant Cytopathology

Cytopathology-2015 is moderated by Dr. Qing Kay Li from The Johns Hopkins University School of Medicine, USA.

We are thankful to our below Honorable guests and Keynote Speakers for their generous support and suggestions.

Sin Hang Lee– Milford Molecular Diagnostics, USA

Yao-Shan Fan - University of Miami Miller School of Medicine, USA

Sahar Samaha- Miraca Life Sciences, USA

Qing Kay Li- The Johns Hopkins University School of Medicine, USA

Ahmed El-Habashi - Cairo University, Egypt

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

  • Turn Cytopathology’s Crisis into Opportunity: Sin Hang Lee, Milford Molecular Diagnostics, USA.
  • The 2013 ASCO/CAP recommendations on HER2 testing in breast cancer have increased equivocal HER2 FISH results and the use of anti-HER2 therapies: Yao-Shan Fan, University of Miami Miller School of Medicine, USA
  • Value of Cytopathology in the diagnosis of respiratory diseases: Qing Kay Li, The Johns Hopkins University School of Medicine, USA  
  • Anal Intraepithelial Neoplasia- Sahar Samaha, Miraca Life Sciences, USA
  • Principles of Cytology: Cytology is Different: Ahmed El-Habashi, Cairo University, Egypt

Various sessions were chaired and co-chaired by: Sin Hang Lee, Milford Molecular Diagnostics, USA, Sahar Samaha, Miraca Life Sciences, USA, Yao-Shan Fan, University of Miami Miller School of Medicine, USA, The Johns Hopkins University School of Medicine, USA.

Workshop at Cytopathology-2015

  • Combine Pap smear and HPV genotyping by DNA sequencing in cytopathology practice for optimum patient care by Sin Hang Lee, Milford Molecular Diagnostics, USA
  • Thyroid lesions fine needle aspiration Cytology: Comprehensive cytomorphology and update reporting by Ahmed El-Habashi, Cairo University, Egypt

OMICS Group has taken the privilege of felicitating Cytopathology-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cytopathology-2015. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Cytopathology as a special issue.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, OMICS Group would like to announce the commencement of the “2nd International Conference on Cytopathology" to be held during August 11-12, 2016 at Birmingham, 

 Let us meet Again @ Cytopathology-2016

 


Past Reports  Gallery  

Pathology 2015

Pathology 2015

 

We gratefully thank all our wonderful speakers, conference attendees, students, associations and exhibitors for making Pathology-2015 Conference the best ever!

 

In 2015, the conference took a new direction, broadening its focus beyond the laboratories to cover all aspects of Pathology. This has provided a unique opportunity for academic and Laboratory-wide communication and collaboration and has positioned the conference as the OMICS International's annual Clinical premier event.

 

The 4th International Conference and Exhibition on Pathology, hosted by the OMICS International was held during July 13-15, 2015 at Hilton New Orleans Airport Hotel, New Orleans, USA  based on the theme “Technological Construction of Pathology". Benevolent response was received from the Editorial Board Members of OMICS International Journals along with scientists, researchers, students and leaders from various fields of Pathology, who made this event a grand success. OMICS Group will acknowledge with gratitude the support by all the Editorial Board Members of Journal of Clinical & Experimental Pathology and Journal of Plant Pathology & Microbiology for their valuable suggestions for up growth of the Organization.

 

The conference was initiated with the Honorable presence of the Keynote forum. The list includes:

Gene N Herbek, President of College of American Pathologists(CAP), USA

Clay J Cockerell, World Renowned Leader in Dermatopathology, USA

Kim Solez, Professor, University Of Alberta, Canada

James Michaelson, Director, Harvard University, USA

Haodong Xu, Professor, University of California Los Angeles, USA

Gerard Lozanski, The Ohio state University, USA

K H Ramesh, Director, Montefiore Medical Center, USA

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Anatomical Pathology

Clinical Pathology

Dermatopathology

Renal Pathology

Oral and Maxillofacial Pathology

Forensic Pathology

Veterinary Pathology

e-Pathology

Molecular Pathology

Surgical Pathology                                                        

OMICS International offers its heartfelt appreciation to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. OMICS International also took privilege to felicitate the Organizing Committee Members, Editorial Board Members and Media Partners who supported this event.

 


Past Reports  Proceedings  Gallery  

Occupational Health-2015

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects, 4th International Conference & Exhibition on Occupational Health & Safety, hosted by the OMICS International was held during August 24-25, 2015, at Toronto Airport Marriott Hotel, Toronto, Canada. Generous response and active participation received from the Researchers, Scientists of Occupational Health research institutes, Principal Investigators and Editorial Board Members of OMICS International helped in making this meeting an ostentatious success.

 

Occupational Health-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Brett Webb, PSHSA, Canada and we also very grateful to Dr. Muhammed Wasif Rashid Chaudhary, Ahalia Hospital, UAE who contributed a lot for the smooth functioning of this event.

 

The highlights of the meeting were the eponymous lectures, delivered by Richard Hanowski of    Virginia Tech Transportation Institute, USA; Maria Meimei Brevidelli, Paulista University, Brazil; Kiyomi Taniyama, Kure Medical Center and Chugoku Cancer Center, Japan and Muhammed Wasif Rashid Chaudhary, Ahalia Hospital, UAE. The ardent talks were of great interest and it established a new prospect and hope on ongoing projects and au courant arenas in Occupational Health and Safety. For the scientific sessions like Women and Occupational Health, Construction and Ergonomics, Occupational Disease and Human Health, Occupational Medicine and Therapy, Infectious Disease and Epidemiology and Agricultural Health and Environmental Health & Safety.

 

 


Past Reports  Proceedings  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 10-12, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
cytopathology@conferenceseries.net
Sponsors / Exhibiting / Advertising.
cytopathology@omicsgroup.com
General Queries.
histopathology@insightconferences.com

View Proceedings of Previous Conferences

Cytopathology 2016
Pathology 2015
Pathology 2014
Medical Case Reports 2016
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.